Barriers to HPV Vaccination Among Teens – Barriers to human papillomavirus (HPV) vaccination among adolescents in the U.S. range from financial concerns and parental attitudes to social influences and concerns about the vaccination’s effect on sexual behavior.
More Parents Say They Won’t Vaccinate Daughters Against HPV, Researchers Find — Parents increasingly concerned about potential side effects, research shows – A rising percentage of parents say they won’t have their teen daughters vaccinated to protect against the human papilloma virus, even though physicians are increasingly recommending adolescent vaccinations. More than 2 in 5 parents surveyed believe the HPV vaccine is unnecessary, and a growing number worry about potential side effects.
HPV vaccine reduces infection, even in unvaccinated — Study shows evidence of herd protection – The HPV vaccine not only has resulted in a decrease in human papillomavirus infection in immunized teens but also in teens who were not immunized. The study is believed to be the first to show a substantial decrease in HPV infection in a community setting as well as herd protection ? a decrease in infection rates among unimmunized individuals that occurs when a critical mass of people in a community is immunized against a contagious disease.
Cervical disease sufferers could benefit from HPV vaccine – HPV vaccination does not reduce progression to cervical disease in women, but vaccinated women had less frequent subsequent cervical disease. Women who are diagnosed with pre-cancerous cervical conditions after receiving the HPV vaccine can still benefit from a considerably reduced risk of reoccurring disease.
Regular smear tests boost chances of cure from 66 percent to 92 percent — Research: Screening and cervical cancer: A population-based cohort study – Women who undergo Pap tests have higher survival rates of cervical cancer. Women can boost their chances of surviving cervical cancer substantially through regular cervical screening, claims a research paper published in BMJ.
The cervical cancer DNA test that could help cut cervical cancer deaths — HPV DNA Test ‘improves cancer screening’ – Implementation of HPV DNA testing in cervical screening leads to earlier detection of clinically relevant CIN grade 2 or worse, which when adequately treated, improves protection against CIN grade 3 or worse and cervical cancer. Early detection of high-grade cervical legions caused by HPV16 was a major component of this benefit.
Study shows intrauterine devices may lower risk for developing cervical cancer – IUDs or intrauterine contraceptive devices could substantially reduce the risk of women developing cervical cancer, revealed by researchers in a recent study in Lancet Oncology.
Many clinicians may be screening for cervical cancer too frequently — Many physicians reported overscreening women by using both the HPV and Pap tests annually. – Many physicians reported overscreening women by using both the HPV and Pap tests annually. Clinical guidelines recommend screening low-risk women for cervical cancer every three years after age 30.
Benefit of HPV Vaccination, Frequent Screening for Women over 41 is Likely to be Low – The overall potential benefits of human papillomavirus (HPV) vaccinations or frequent HPV screenings for women over the age of 41 are low, concludes a new study published online February 15 in the Journal of the National Cancer Institute.